Success of tocilizumab in RA patients with remission induction and sustained efficacy after discontinuation.
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms SURPRISE
- 10 Jun 2017 Biomarkers information updated
- 05 Jan 2016 Results published in the Annals of the Rheumatic Diseases
- 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.